Details of the Drug | DrugMAP

General Information of Drug (ID: DM776EU)

Drug Name

TVI-Brain-1 cancer vaccine

Indication

Disease Entry	ICD 11	Status	REF
Astrocytoma	2A00.0Y	Phase 2	[1]
Brain cancer	2A00	Phase 2	[2]
Glioma	2A00.0	Phase 2	[3]
Pneumococcal infection	CA00-CA40	Phase 2	[3]
Recurrent glioblastoma	2A00.00	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0ZR6E

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	ClinicalTrials.gov (NCT01290692) Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma. U.S. National Institutes of Health.